Participated · Series A · Jul 2026

Flourish Health delivers intensive in-home mental health care for children and young adults through psychiatrist-led Care Pods composed of a child and adolescent psychiatrist, a licensed therapist, a patient guide, and a family guide. The company built a proprietary technology platform that integrates patient touchpoints, EMR and prescribing capabilities, workflow automation, team collaboration, and AI to support engagement and coordination while clinicians make clinical decisions. Flourish specializes in three clinical populations: children with externalizing behaviors, young people with multiple suicide attempts or suicide-related hospitalizations, and patients with complex needs and family situations often turned away by other clinics. Studies run with multiple major health plans report large reductions in hospitalization (70–96%), residential treatment (69–90%), and sustained decreases in higher levels of care post-discharge (80–95%). Flourish commits to beginning care within one week of referral, reports 92% month-over-month retention during its 12-month programs, and says those programs cost less than one month of inpatient treatment.

Participated · Series A · Feb 2023

Andrena, the team behind the DAWN token, is creating a decentralized physical infrastructure network (DePIN) protocol on the Solana blockchain to reshape how internet connectivity is provided. The protocol intends to replace or supplement centralized internet service models with a blockchain-powered, community-run alternative. Built by @dawninternet, the project leverages Solana’s speed and scalability to coordinate and incentivize network participants. To further its development, Andrena secured $13 million in Series B funding. The investment validates market interest in decentralized connectivity solutions. No information on revenue, user numbers, or other operating metrics was released.

Participated · Seed · Dec 2017

Clora operates a two-sided on-demand marketplace that connects biotech consultants with biopharma and medical-device companies to staff specialized projects. The platform segments expertise into 29 specialties, from legal and accounting to GxP Quality Assurance and Safety/Pharmacovigilance. Clora emphasizes building a reputation system that uses expert vetting to evaluate practitioners and reduce noisy endorsements. Founders Rahul Chaturvedi and Leaya Martelli conceived the idea while working in the pharmaceutical industry; Chaturvedi previously headed clinical affairs at Avedro, GI Dynamics, and Kaleido Biosciences and left his job in September 2016 to build Clora full-time. The company announced a $3.3M seed round to support its growth. Management says the service aims to cut hiring delays and costs, accelerating therapeutic launches and lowering end prices for therapies.